These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3739696)

  • 1. Effects of phenylpropanolamine on ostial and nasal airway resistance in healthy individuals.
    Melén I; Andréasson L; Ivarsson A; Jannert M; Johansson CJ
    Acta Otolaryngol; 1986; 102(1-2):99-105. PubMed ID: 3739696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis.
    Melén I; Friberg B; Andréasson L; Ivarsson A; Jannert M; Johansson CJ
    Acta Otolaryngol; 1986; 101(5-6):494-500. PubMed ID: 3727982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patency of the maxillary sinus ostium in healthy individuals.
    Jannert M; Andréasson L; Ivarsson A; Nielsen A
    Acta Otolaryngol; 1984; 97(1-2):137-49. PubMed ID: 6689822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of topical phenylpropanolamine on nasal secretion and nasal airway resistance after histamine challenge in man.
    Löth S; Bende M
    Clin Otolaryngol Allied Sci; 1985 Feb; 10(1):15-9. PubMed ID: 4006263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the effect of peroral fenylpropanolamin on the functional size of the human maxillary ostium.
    Aust R; Drettner B; Falck B
    Acta Otolaryngol; 1979; 88(5-6):455-8. PubMed ID: 532621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine.
    Bende M; Andersson KE; Johansson CJ; Sjögren C; Svensson G
    Acta Otolaryngol; 1984; 98(5-6):543-7. PubMed ID: 6084394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the maxillary ostial function in cases with maxillary pain, intrasinusal cysts and chronic sinusitis.
    Jannert M; Andréasson L; Ivarsson A
    Acta Otolaryngol; 1984; 97(3-4):325-34. PubMed ID: 6720309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ostial and nasal patency in chronic maxillary sinusitis. A long-term post-treatment study.
    Melén I; Friberg B; Andréasson L; Ivarsson A; Jannert M; Lindahl L
    Acta Otolaryngol; 1986; 102(5-6):500-8. PubMed ID: 3788549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patency tests of the maxillary ostium in health and disease.
    Jannert M; Andréasson L; Ivarsson A
    Rhinology; 1982 Dec; 20(4):237-42. PubMed ID: 7163742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phenylpropanolamine on human sympathetic nervous system function.
    Lake CR; Chernow B; Zaloga G; Labow J; Quirk R; Hedges SM
    Neuropsychopharmacology; 1988 May; 1(2):163-8. PubMed ID: 3251497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlants of changes in nasal flow/resistance (Rn) measurements.
    Cohen BM
    Allergol Immunopathol (Madr); 1978; 6(3):217-23. PubMed ID: 362874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The patency of the maxillary ostium in relation to body posture.
    Aust R; Drettner B
    Acta Otolaryngol; 1975; 80(5-6):443-6. PubMed ID: 1202917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a topical nasal decongestant in different formulations: the effect of viscosity.
    Johansson CJ; Carlson T; Olsson P; Bende M
    Acta Otolaryngol; 1992 Nov; 112(6):1032-7. PubMed ID: 1481657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vasoconstrictors in perennial non-allergic rhinitis.
    Broms P; Malm L
    Allergy; 1982 Feb; 37(2):67-74. PubMed ID: 7137522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
    Ackerhans M; Jannert M; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the effects of phenylpropanolamine on appetite and food intake.
    Caffry EW; Kissileff HR; Thornton JC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):321-5. PubMed ID: 3575355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenylpropanolamine and isometric exercise on blood pressure.
    Pentel PR; Eisen T
    Int J Obes; 1988; 12(3):199-204. PubMed ID: 3391736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
    Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
    JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of topical phenylpropanolamine on tachyphylaxis and mucociliary clearance in the human nose.
    Holmberg K; Bende M
    J Laryngol Otol; 1988 May; 102(5):408-10. PubMed ID: 3397633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects.
    Howarth P; Walsh S; Robinson C
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():449-52. PubMed ID: 1825579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.